Changes in frequency and pathogens causing acute otitis media in 1995-2003

Pediatric Infectious Disease Journal

Volumn 23, Issue 9, 2004, Pages 824-828

  Casey, Janet R ^a   Pichichero, Michael E ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Acute otitis media; Haemophilus influenzae; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; BETA LACTAMASE; CEFDINIR; CEFPODOXIME; CEFPROZIL; CEFUROXIME; CEPHALOSPORIN; COTRIMOXAZOLE; OXACILLIN; PNEUMOCOCCUS VACCINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; DRUG MEGADOSE; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; IMMUNIZATION; INFANT; MAJOR CLINICAL STUDY; MALE; MORAXELLA CATARRHALIS; MYRINGOTOMY; OTITIS MEDIA; PERSISTENT INFECTION; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; PRIVATE PRACTICE; PROSPECTIVE STUDY; PUBLICATION; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; TREATMENT FAILURE; UNITED STATES; VACCINATION; ACUTE DISEASE; AGE DISTRIBUTION; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; FOLLOW UP; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITALIZATION; INCIDENCE; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE EAR VENTILATION; MULTIDRUG RESISTANCE; MULTIMODALITY CANCER THERAPY; SEX RATIO;

ACUTE DISEASE; AGE DISTRIBUTION; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMBINED MODALITY THERAPY; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INCIDENCE; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE EAR VENTILATION; NEW YORK; OTITIS MEDIA; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; TREATMENT FAILURE;

EID: 6344250800     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000136871.51792.19     Document Type: Article

References (27)

1. Pichichero ME, Reiner SA, Brook I, et al. Controversies in the medical management of persistent and recurrent acute otitis media: recommendations of a clinical advisory committee. Ann Otol Rhinol Laryngol. 2000;109:1-12.
2. Pichichero ME, Pichichero CL. Persistent acute otitis media: I. causative pathogens. Pediatr Infect Dis J. 1995;14:178-83.
3. Block SL, Harrison CJ, Hedrick JA, et al. Penicillin resistant Streptococcus pneumonias in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J. 1995;14:751-759.
4. Brook I, Yocum P. Bacteriology and β-lactamase activity in ear aspirates of acute otitis media that failed amoxicillin therapy. Pediatr Infect Dis J. 1995;14:805-808.
5. Duchin JS, Breiman RF, Diamond A, et al. High prevalence of multi-drug-resistant Streptococcus pneumonias among children in a rural Kentucky community. Pediatr Infect Dis J. 1995;14:745-750.
6. Block SL. Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media. Pediatr Infect Dis J. 1997;16:44S-S56.
7. Pichichero ME, McLinn S, Aronovitz G, et al. Cefprozil treatment of persistent and recurrent acute otitis media. Pediatr Infect Dis J. 1997;16:471-478.
8. Rosenblut A, Santolaya ME, Gonzalez P, et al. Bacterial and viral etiology of acute otitis media in Chilean children. Pediatr Infect Dis J. 2001;20:501-507.
9. Block SL, Hedrick JA, Tyler RD, et al. Microbiology of acute otitis media recently treated with aminopenicillins. Pediatr Infect Dis J. 2001;20:1017-1021.
10. Piglansky L, Leibovitz E, Raiz S, et al. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children. Pediatr Infect Dis J. 2003;22:405-412.
11. Leibovitz E, Piglansky L, Raiz S, et al. Bacteriologic and clinical efficacy of oral gatifloxacin for the treatment of recurrent/nonresponsive acute otitis media: an open label, noncomparative, double tympanocentesis study. Pediat Infect Dis J. 2003;22:943-949.
12. Arguedas A, Sher L, Lopez E, et al. Open label, multicenter study of gatifloxacin treatment of recurrent otitis media and acute otitis media treatment failure. Pediatr Infect Dis J. 2003;22:949-955.
13. Paradise JL, Rockette HE, Colbom DK, et al. Otitis media is 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics. 1997;99:318-333.
14. Klein JO. Otitis media. Clin Infect Dis. 1994;19:823-833.
15. Dowell SF, Butler JC, Giebink GS, et al. Acute otitis media: Management and surveillance in an era of pneumococcal resistance-a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J. 1999;18:1-9.
16. American Academy of Pediatrics and American Academy of Family Physicians treatment guidelines for uncomplicated acute otitis media. Pediatrics. 2004. In press.
17. Leibovitz E. Dagan R. Antibiotic treatment for acute otitis media. Int J Antimicrob Agents. 2000;15:169-177.
18. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344:403-409.
19. Jaloba ML, Windau A, Bajaksouzian S, et al. neumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with acute otitis media. Clin Infect Dis. 2001;33:1489-1494.
20. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J. 2000;19:187-195.
21. Fireman B, Black SB, Shinefield HR, et al. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J. 2003;22:10-16.
22. Harrison CJ. Changes in treatment strategies for acute otitis media after full implementation of the pneumococcal seven valent conjugate vaccine. Pediatr Infect Dis J. 2003;22:S120-S130.
23. Lister PD, Pong A, Chartrand SA, et al. Rationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci: support from in vitro pharmacodynamic studies. Antimicrob Agents Chemother. 1997;41:1926-1932.
24. Seikel K, Shelton S, McCracken GH. Middle ear fluid concentrations of amoxicillin after large dosages in children with acute otitis media. Pediatr Infect Dis J. 1997;16:710-711.
25. Jacobs MR, Dagan R, Appelbaum PC, et al. Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media. Antimicrob Agents Chemother. 1998;42:589-595.
26. Block SL, Hedrick J, Harrison CJ, et al. Pneumococcal serotypes from acute otitis media in rural Kentucky. Pediatr Infect Dis J. 2002;21:859-865.
27. McEllistrem MC, Adams J, Mason EO, et al. Epidemiology of acute otitis media caused by Streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine. J Infect Dis. 2003;188:1679-1684.